Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Venuvi GM 1mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Dr Kumars Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Venuvi GM 1mg/500mg/0.3mg Tablet SR

Venuvi GM 1mg/500mg/0.3mg SR tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medicine as prescribed, even if feeling well or achieving target blood sugar levels. Discontinuing treatment without medical consultation risks elevated blood glucose, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management program, requiring adherence to a healthy diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms such as sweating, dizziness, headache, and tremors, and know how to treat them. Maintain consistent mealtimes and carry a fast-acting glucose source, like sugary foods or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Inform your doctor of any history of heart disease before commencing treatment, as this medication may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood sugar monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Venuvi GM 1mg/500mg/0.3mg Tablet SR

No text was provided to rephrase. Please provide the text you wish to have rewritten.

Uses of Venuvi GM 1mg/500mg/0.3mg Tablet SR

Managing type 2 diabetes

Major Benefits of Venuvi GM 1mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Venuvi GM 1mg/500mg/0.3mg Tablet SR whole; do not chew, crush, or divide it. Administer on an empty stomach.

Common Side effects of Venuvi GM 1mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Venuvi GM 1mg/500mg/0.3mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Venuvi GM 1mg/500mg/0.3mg Extended-Release Tablets on an empty stomach.

How Venuvi GM 1mg/500mg/0.3mg Tablet SR works:

Venuvi GM SR tablets (1mg/500mg/0.3mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Venuvi GM 1mg/500mg/0.3mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Venuvi GM 1mg/500mg/0.3mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Venuvi GM 1mg/500mg/0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Venuvi GM 1mg/500mg/0.3mg Tablet SR, as its use may be unsafe. Medical advice is recommended. Furthermore, Venuvi GM 1mg/500mg/0.3mg Tablet SR is unsuitable for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Venuvi GM 1mg/500mg/0.3mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, initiate treatment with a reduced Venuvi GM 1mg/500mg/0.3mg SR tablet dose; it's contraindicated in severe cases.

What if you forget to take Venuvi GM 1mg/500mg/0.3mg Tablet SR :

Should you forget to take a Venuvi GM 1mg/500mg/0.3mg Tablet SR, ingest the dose immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your typical medication regimen. Avoid taking a double dose.

Facts to Know About Venuvi GM 1mg/500mg/0.3mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Venuvi GM 1mg/500mg/0.3mg Tablet SR

Venuvi GM SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Venuvi GM 1mg/500mg/0.3mg SR Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Venuvi GM 1mg/500mg/0.3mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Venuvi GM 1mg/500mg/0.3mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Venuvi GM 1mg/500mg/0.3mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medicine. Keep it out of reach of children, pets, and others.
Venuvi GM 1mg/500mg/0.3mg...
73
MRP 89
17% off